Relationship between vemurafenib plasma concentrations and survival outcomes in patients with advanced melanoma

被引：0

作者：

Ganessan Kichenadasse

Jim Henry Hughes

John O. Miners

Arduino A. Mangoni

Andrew Rowland

Ashley M. Hopkins

Michael J. Sorich

机构：

[1] Flinders University,Department of Clinical Pharmacology, College of Medicine and Public Health

[2] Flinders Medical Centre/Flinders University,Department of Medical Oncology, Flinders Centre for Innovation in Cancer

[3] University of South Australia,undefined

来源：

Cancer Chemotherapy and Pharmacology | 2020年 / 85卷

关键词：

Vemurafenib; Melanoma; Threshold concentration; Survival;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：615 / 620

页数：5

共 50 条

[41] An UPLC-MS/MS method for the quantification of BRAF inhibitors (vemurafenib, dabrafenib) and MEK inhibitors (cobimetinib, trametinib, binimetinib) in human plasma. Application to treated melanoma patients [J].

Rousset, Marine ;

Titier, Karine ;

Bouchet, Stephane ;

Dutriaux, Caroline ;

Pham-Ledard, Anne ;

Prey, Sorilla ;

Canal-Raffin, Mireille ;

Molimard, Mathieu .

CLINICA CHIMICA ACTA, 2017, 470 :8-13

[42] Disparities in Survival Outcomes Among Patients With Metastatic Melanoma in Texas [J].

Olateju, Olajumoke A. ;

Mgbere, Osaro ;

Thornton, J. Douglas ;

Zeng, Zhen ;

Essien, Ekere J. .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2024, 47 (11) :517-525

[43] 18F-FDG PET/CT longitudinal studies in patients with advanced metastatic melanoma for response evaluation of combination treatment with vemurafenib and ipilimumab [J].

Sachpekidis, Christos ;

Kopp-Schneider, Annette ;

Hakim-Meibodi, Lara ;

Dimitrakopoulou-Strauss, Antonia ;

Hassel, Jessica C. .

MELANOMA RESEARCH, 2019, 29 (02) :178-186

[44] Survival of advanced melanoma patients treated with immunotherapy and targeted therapy: A real-world study [J].

Yu, Su-Yeon ;

Mckavanagh, Dan ;

McPherson, Ian ;

Walpole, Euan ;

Atkinson, Victoria ;

Hollingworth, Samantha .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 (10) :1371-1379

[45] Association between surgical delay and outcomes among patients with invasive cutaneous melanoma [J].

Hewitt, D. Brock ;

Beane, Joal D. ;

Grignol, Valerie P. ;

Contreras, Carlo M. .

AMERICAN JOURNAL OF SURGERY, 2023, 226 (05) :631-639

[46] Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study [J].

Chapman, P. B. ;

Robert, C. ;

Larkin, J. ;

Haanen, J. B. ;

Ribas, A. ;

Hogg, D. ;

Hamid, O. ;

Ascierto, P. A. ;

Testori, A. ;

Lorigan, P. C. ;

Dummer, R. ;

Sosman, J. A. ;

Flaherty, K. T. ;

Chang, I. ;

Coleman, S. ;

Caro, I. ;

Hauschild, A. ;

McArthur, G. A. .

ANNALS OF ONCOLOGY, 2017, 28 (10) :2581-2587

[47] Feasibility of monitoring advanced melanoma patients using cell-free DNA from plasma [J].

Gangadhar, Tara C. ;

Savitch, Samantha L. ;

Yee, Stephanie S. ;

Xu, Wei ;

Huang, Alexander C. ;

Harmon, Shannon ;

Lieberman, David B. ;

Soucier, Devon ;

Fan, Ryan ;

Black, Taylor A. ;

Morrissette, Jennifer J. D. ;

Salathia, Neeraj ;

Waters, Jill ;

Zhang, Shile ;

Toung, Jonathan ;

van Hummelen, Paul ;

Fan, Jian-Bing ;

Xu, Xiaowei ;

Amaravadi, Ravi K. ;

Schuchter, Lynn M. ;

Karakousis, Giorgos C. ;

Hwang, Wei-Ting ;

Carpenter, Erica L. .

PIGMENT CELL & MELANOMA RESEARCH, 2018, 31 (01) :73-81

[48] Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies [J].

Bhatty, Minny ;

Kato, Shumei ;

Piha-Paul, Sarina A. ;

Naing, Aung ;

Subbiah, Vivek ;

Huang, Helen J. ;

Karp, Daniel D. ;

Tsimberidou, Apostolia M. ;

Zinner, Ralph G. ;

Hwu, Wen-Jen ;

Javle, Milind ;

Patel, Sapna P. ;

Hu, Mimi, I ;

Varadhachary, Gauri R. ;

Conley, Anthony P. ;

Ramzanali, Nishma M. ;

Holley, Veronica R. ;

Kurzrock, Razelle ;

Meric-Bernstam, Funda ;

Chae, Young Kwang ;

Kim, Kevin B. ;

Falchook, Gerald S. ;

Janku, Filip .

CANCER, 2019, 125 (03) :463-472

[49] Changes in outcomes and factors associated with survival in melanoma patients with brain metastases [J].

Hasanov, Merve ;

Milton, Denai R. ;

Davies, Alicia Bea ;

Sirmans, Elizabeth ;

Saberian, Chantal ;

Posada, Eliza L. ;

Opusunju, Sylvia ;

Gershenwald, Jeffrey E. ;

Torres-Cabala, Carlos A. ;

Burton, Elizabeth M. ;

Colen, Rivka R. ;

Huse, Jason T. ;

Glitza Oliva, Isabella C. ;

Chung, Caroline ;

McAleer, Mary Frances ;

McGovern, Susan L. ;

Yeboa, Debra N. ;

Kim, Betty Y. S. ;

Prabhu, Sujit S. ;

McCutcheon, Ian E. ;

Weinberg, Jeffrey S. ;

Lang, Frederick F. ;

Tawbi, Hussein A. ;

Li, Jing ;

Haydu, Lauren E. ;

Davies, Michael A. ;

Ferguson, Sherise D. .

NEURO-ONCOLOGY, 2023, 25 (07) :1310-1320

[50] Survival and treatment outcomes in patients with leptomeningeal disease from metastatic melanoma [J].

Saberian, Chantal ;

Milton, Denai R. ;

Simon, Julie ;

Amaria, Rodabe N. ;

Diab, Adi ;

Mcquade, Jennifer ;

Patel, Sapna P. ;

Tawbi, Hussein ;

Yee, Cassian ;

Wong, Michael K. ;

Mccutcheon, Ian E. ;

Davies, Michael A. ;

Ferguson, Sherise D. ;

Glitza Oliva, Isabella C. .

NEURO-ONCOLOGY PRACTICE, 2024, :452-463

← 1 2 3 4 5 →